JP5266267B2 - 水素含有生体適用液の製造方法及び製造装置 - Google Patents
水素含有生体適用液の製造方法及び製造装置 Download PDFInfo
- Publication number
- JP5266267B2 JP5266267B2 JP2010042647A JP2010042647A JP5266267B2 JP 5266267 B2 JP5266267 B2 JP 5266267B2 JP 2010042647 A JP2010042647 A JP 2010042647A JP 2010042647 A JP2010042647 A JP 2010042647A JP 5266267 B2 JP5266267 B2 JP 5266267B2
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- container
- concentration
- liquid
- biological application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title claims abstract description 423
- 239000001257 hydrogen Substances 0.000 title claims abstract description 393
- 229910052739 hydrogen Inorganic materials 0.000 title claims abstract description 393
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000013060 biological fluid Substances 0.000 title claims description 17
- 238000004519 manufacturing process Methods 0.000 claims abstract description 32
- 239000007788 liquid Substances 0.000 claims description 158
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 98
- 230000035699 permeability Effects 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 13
- 238000001802 infusion Methods 0.000 abstract description 48
- 239000000243 solution Substances 0.000 abstract description 39
- -1 infusion Substances 0.000 abstract description 21
- 238000002347 injection Methods 0.000 abstract description 13
- 239000007924 injection Substances 0.000 abstract description 13
- 230000008569 process Effects 0.000 abstract description 12
- 239000000082 organ preservation Substances 0.000 abstract description 2
- 239000002504 physiological saline solution Substances 0.000 description 67
- 239000007789 gas Substances 0.000 description 36
- 239000008280 blood Substances 0.000 description 35
- 210000004369 blood Anatomy 0.000 description 34
- 239000012528 membrane Substances 0.000 description 29
- 210000004379 membrane Anatomy 0.000 description 26
- 239000010836 blood and blood product Substances 0.000 description 22
- 229940125691 blood product Drugs 0.000 description 22
- 238000003860 storage Methods 0.000 description 18
- 150000002431 hydrogen Chemical class 0.000 description 17
- 230000036961 partial effect Effects 0.000 description 14
- 239000004743 Polypropylene Substances 0.000 description 13
- 229920001155 polypropylene Polymers 0.000 description 13
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 12
- 229920006395 saturated elastomer Polymers 0.000 description 12
- 239000012466 permeate Substances 0.000 description 10
- 239000003761 preservation solution Substances 0.000 description 10
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical group [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000004800 polyvinyl chloride Substances 0.000 description 9
- 229920000915 polyvinyl chloride Polymers 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000012298 atmosphere Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000005868 electrolysis reaction Methods 0.000 description 8
- 238000004555 blood preservation Methods 0.000 description 7
- 238000000502 dialysis Methods 0.000 description 7
- 239000000385 dialysis solution Substances 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 239000012503 blood component Substances 0.000 description 5
- 239000000084 colloidal system Substances 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000001066 destructive effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010063837 Reperfusion injury Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 206010011951 Decompression Sickness Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 238000002619 cancer immunotherapy Methods 0.000 description 1
- 238000009566 cancer vaccine Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000011549 displacement method Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000162 organ preservation solution Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000011232 storage material Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Images
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010042647A JP5266267B2 (ja) | 2010-02-26 | 2010-02-26 | 水素含有生体適用液の製造方法及び製造装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010042647A JP5266267B2 (ja) | 2010-02-26 | 2010-02-26 | 水素含有生体適用液の製造方法及び製造装置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011177242A JP2011177242A (ja) | 2011-09-15 |
| JP2011177242A5 JP2011177242A5 (enExample) | 2013-04-04 |
| JP5266267B2 true JP5266267B2 (ja) | 2013-08-21 |
Family
ID=44689477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010042647A Expired - Fee Related JP5266267B2 (ja) | 2010-02-26 | 2010-02-26 | 水素含有生体適用液の製造方法及び製造装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5266267B2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5940753B1 (ja) * | 2016-03-07 | 2016-06-29 | 株式会社日本トリム | 水素含有腹膜透析液の製造装置 |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013119525A (ja) * | 2011-12-06 | 2013-06-17 | New I Ten Rin Enterprise Co Ltd | 容器内の溶液に水素イオンを含有させる装置及びその方法 |
| CN104245536B (zh) * | 2012-04-20 | 2017-05-03 | 株式会社奈纳喷射日本 | 气密性优良的容器及容器的气体分子或挥发成分的保持方法 |
| JP5792240B2 (ja) * | 2012-08-27 | 2015-10-07 | 武夫 西 | 注射シミュレータ用模擬剤及びその製造方法と製造装置 |
| JP2014118191A (ja) * | 2012-12-18 | 2014-06-30 | Hikari Mirai:Kk | 対象物に対する水素ガスの溶解方法 |
| JP6076763B2 (ja) * | 2013-02-01 | 2017-02-08 | 水素健康医学ラボ株式会社 | 溶存水素検出装置及び溶存水素検出方法 |
| JP2014161605A (ja) * | 2013-02-27 | 2014-09-08 | Nippon Torimu:Kk | 水素付加装置および腹膜透析装置 |
| JP6183832B2 (ja) * | 2013-06-19 | 2017-08-23 | 扶桑薬品工業株式会社 | 酸化ストレス抑制型透析用剤およびその調製方法 |
| WO2015137499A2 (ja) * | 2014-03-13 | 2015-09-17 | ＭｉＺ株式会社 | 水素含有生体適用液の製造方法及びそのための外装体 |
| JP6345952B2 (ja) * | 2014-03-13 | 2018-06-20 | ナチュラン・インターナショナル有限会社 | 医療用容器 |
| JP2018122938A (ja) * | 2018-04-10 | 2018-08-09 | 株式会社光未来 | 対象物に対する水素ガスの溶解方法 |
| JP7037663B2 (ja) * | 2018-09-21 | 2022-03-16 | 株式会社日本トリム | 水素含有腹膜透析液の製造装置 |
| JP7219894B2 (ja) * | 2019-02-28 | 2023-02-09 | 岩谷産業株式会社 | 水素溶存液製造装置及び水素溶存液製造方法 |
| JP7022088B2 (ja) * | 2019-03-07 | 2022-02-17 | 株式会社日本トリム | 水素付加装置及び水素付加方法 |
| JP7037515B2 (ja) * | 2019-03-07 | 2022-03-16 | 株式会社日本トリム | 水素付加装置及び水素透過膜の消耗度判定方法 |
| JP7019910B2 (ja) * | 2020-07-21 | 2022-02-16 | ＭｉＺ株式会社 | 薬の副作用、薬の副作用に関連する症状、および／または、治療に伴う副作用を予防および／または改善するための組成物 |
| JP2022141396A (ja) * | 2021-03-15 | 2022-09-29 | 広島化成株式会社 | 水素含有点滴溶液の製造装置および製造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3940967B2 (ja) * | 1997-07-08 | 2007-07-04 | 栗田工業株式会社 | 電子材料用洗浄水の製造方法及び電子材料の洗浄方法 |
| WO1999010286A1 (en) * | 1997-08-27 | 1999-03-04 | Miz Co., Ltd. | Electrolytic cell and electrolyzed water generating device |
| JP3933403B2 (ja) * | 2001-02-28 | 2007-06-20 | 株式会社日本トリム | 電解還元水およびその製造方法 |
| JP4653945B2 (ja) * | 2003-10-24 | 2011-03-16 | ミズ株式会社 | 薬理機能水、およびその用途 |
| JPWO2005082384A1 (ja) * | 2004-02-27 | 2008-03-06 | 株式会社日本トリム | 人工生理的塩類溶液およびその製造方法 |
| JP2007254435A (ja) * | 2006-03-27 | 2007-10-04 | Takaoka Kasei Kogyo Kk | 抗がん用機能水 |
| JP4004523B1 (ja) * | 2006-04-21 | 2007-11-07 | 株式会社日本トリム | 透析液調製用水およびそれを用いた透析液、透析液の製造方法ならびに透析装置 |
-
2010
- 2010-02-26 JP JP2010042647A patent/JP5266267B2/ja not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5940753B1 (ja) * | 2016-03-07 | 2016-06-29 | 株式会社日本トリム | 水素含有腹膜透析液の製造装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011177242A (ja) | 2011-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4486157B1 (ja) | 水素含有生体適用液の製造方法及び製造装置 | |
| JP5266267B2 (ja) | 水素含有生体適用液の製造方法及び製造装置 | |
| US20250161547A1 (en) | Regenerative peritoneal dialysis system | |
| EP3439712B1 (en) | Peritoneal dialysate fluid generation system with integrated cycler | |
| JP5859558B2 (ja) | 赤血球の照射及び嫌気性保存 | |
| JP6183832B2 (ja) | 酸化ストレス抑制型透析用剤およびその調製方法 | |
| BR112017022126B1 (pt) | Aparelho de acumulação, aparelho de produção de solução e seu uso e aparelho de banho de óxido nítrico (no) e método para acumular | |
| US11284616B2 (en) | Irradiation of red blood cells and anaerobic storage | |
| HK1151455B (en) | Process and apparatus for producing hydrogen-containing biocompatible solution | |
| US12089589B2 (en) | Irradiation of red blood cells and anaerobic storage | |
| TWI574685B (zh) | A method for producing a suitable liquid for living organisms containing hydrogen, and an external preparation for the liquid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130218 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130218 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20130218 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20130318 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130416 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130502 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5266267 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |